VTGN Investors Encouraged to Seek Lead Plaintiff Role in Vistagen Therapeutics Securities Class Action Case with Johnson Fistel
(NASDAQ:VTGN), SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) securities between April 1, 2024 and December 16, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses for […]